Clinical Trial Update: A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis [Phase 2]

View source ↗

Summary

Phase II controlled trial evaluating velafermin for prevention of oral mucositis and stomatitis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis
• Stomatitis

Drugs mentioned

• Velafermin (velafermin)

Snippet

Sponsor: CuraGen Corporation | Conditions: Oral Mucositis, Stomatitis | Phase 2 | Status: COMPLETED